In type 2 diabetes mellitus (T2DM) patients, in addition to impaired insulin secretion and impaired insulin-induced glucose uptake, enhanced endogenous glucose production (EGP) is known to contribute to the development of hyperglycemia [8]. The gene discussed is INS; the disease is type 2 diabetes mellitus.